Association Between Prophylactic Implantable Cardioverter-Defibrillators and Survival in Patients With Left Ventricular Ejection Fraction Between 30% and 35%

IMPORTANCE: Clinical trials of prophylactic implantable cardioverter-defibrillators (ICDs) have included a minority of patients with a left ventricular ejection fraction (LVEF) between 30% and 35%. Because a large number of ICDs in the United States are implanted in such patients, it is important to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Al-Khatib, Sana M., Hellkamp, Anne S., Fonarow, Gregg C., Mark, Daniel B., Curtis, Lesley H., Hernandez, Adrian F., Anstrom, Kevin J., Peterson, Eric D., Sanders, Gillian D., Al-Khalidi, Hussein R., Hammill, Bradley G., Heidenreich, Paul A., Hammill, Stephen C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4122230/
https://ncbi.nlm.nih.gov/pubmed/24893088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2014.5310
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados